Symbols / BWAY Stock $17.17 +2.75% BrainsWay Ltd.
BWAY (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Ratings
Current target
$17.17
Low
$15.00
High
$16.00
Mean
$15.33
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-12 | main | HC Wainwright & Co. | Buy → Buy | $15 |
| 2026-01-26 | main | HC Wainwright & Co. | Buy → Buy | $30 |
| 2025-12-08 | main | HC Wainwright & Co. | Buy → Buy | $24 |
| 2025-11-13 | main | HC Wainwright & Co. | Buy → Buy | $18 |
| 2025-11-12 | main | Northland Capital Markets | Outperform → Outperform | $23 |
| 2025-08-25 | reit | HC Wainwright & Co. | Buy → Buy | $17 |
| 2025-08-14 | main | Northland Capital Markets | Outperform → Outperform | $19 |
| 2025-08-14 | main | HC Wainwright & Co. | Buy → Buy | $17 |
| 2025-06-12 | reit | HC Wainwright & Co. | Buy → Buy | $16 |
| 2025-06-09 | reit | HC Wainwright & Co. | Buy → Buy | $16 |
| 2025-03-12 | reit | HC Wainwright & Co. | Buy → Buy | $16 |
| 2024-12-23 | reit | HC Wainwright & Co. | Buy → Buy | $16 |
| 2024-10-21 | reit | HC Wainwright & Co. | Buy → Buy | $16 |
| 2024-10-03 | main | Northland Capital Markets | Outperform → Outperform | $13 |
| 2024-09-16 | reit | HC Wainwright & Co. | Buy → Buy | $16 |
| 2024-08-08 | main | HC Wainwright & Co. | Buy → Buy | $16 |
| 2024-08-07 | main | Northland Capital Markets | Outperform → Outperform | $11 |
| 2024-06-05 | reit | HC Wainwright & Co. | Buy → Buy | $15 |
| 2024-05-09 | main | Oppenheimer | Outperform → Outperform | $11 |
| 2024-05-09 | main | HC Wainwright & Co. | Buy → Buy | $15 |
- Are medical stocks lagging Brainsway (BWAY) this year? - MSN Fri, 08 May 2026 13
- Harel Insurance boosts stake in Brainsway (NASDAQ: BWAY) to 6.8% — 2.68M shares - Stock Titan ue, 05 May 2026 10
- Brainsway (BWAY) Projected to Post Quarterly Earnings on Wednesday - MarketBeat Wed, 06 May 2026 10
- Why (BWAY) Price Action Is Critical for Tactical Trading - Stock Traders Daily Wed, 06 May 2026 15
- BrainsWay Ltd (BWAY) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 68/100 - GuruFocus Wed, 22 Apr 2026 23
- Brainsway (BWAY) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance Mon, 13 Apr 2026 07
- BrainsWay opens May 13 with earnings release, 8:30 a.m. webcast - Stock Titan Wed, 29 Apr 2026 07
- BrainsWay - Depositary receipt (BWAY) price target decreased by 59.41% to 0.05 - MSN Wed, 06 May 2026 01
- Brainsway (NASDAQ:BWAY) Shares Gap Up - Here's Why - MarketBeat Mon, 13 Apr 2026 07
- Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance Mon, 13 Apr 2026 07
- BWAY SEC Filings - Brainsway Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan Sun, 03 May 2026 20
- BrainsWay management takes virtual healthcare conference slot Wednesday - Stock Titan Mon, 13 Apr 2026 12
- BrainsWay says insurer shifts could widen access to drug-free mental health care - Stock Titan Wed, 15 Apr 2026 07
- Here's Why Momentum in Brainsway (BWAY) Should Keep going - Yahoo Finance hu, 26 Mar 2026 07
- BWAY Shares Gain on Optum Expanding Deep TMS Coverage for Teens - Yahoo Finance ue, 23 Dec 2025 08
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
52.23
+27.33%
|
41.02
+29.04%
|
31.79
+16.96%
|
27.18
|
| Operating Revenue |
|
52.23
+27.33%
|
41.02
+29.04%
|
31.79
+16.96%
|
27.18
|
| Cost Of Revenue |
|
12.84
+23.04%
|
10.44
+25.60%
|
8.31
+16.54%
|
7.13
|
| Reconciled Cost Of Revenue |
|
12.84
+23.04%
|
10.44
+43.95%
|
7.25
+19.82%
|
6.05
|
| Gross Profit |
|
39.39
+28.79%
|
30.58
+30.26%
|
23.48
+17.10%
|
20.05
|
| Operating Expense |
|
35.06
+20.12%
|
29.19
+2.65%
|
28.44
-13.12%
|
32.73
|
| Research And Development |
|
9.60
+33.56%
|
7.19
+7.88%
|
6.67
-13.19%
|
7.68
|
| Selling General And Administration |
|
25.46
+15.73%
|
22.00
+1.67%
|
21.64
-11.02%
|
24.32
|
| Selling And Marketing Expense |
|
18.93
+16.85%
|
16.20
+173.70%
|
5.92
-18.93%
|
7.30
|
| General And Administrative Expense |
|
6.53
+12.59%
|
5.80
-63.12%
|
15.72
-7.62%
|
17.02
|
| Salaries And Wages |
|
—
|
12.19
-6.68%
|
13.06
-4.60%
|
13.69
|
| Other Gand A |
|
6.53
+12.59%
|
5.80
+118.43%
|
2.65
-20.08%
|
3.32
|
| Total Expenses |
|
47.90
+20.89%
|
39.62
+7.84%
|
36.74
-7.82%
|
39.86
|
| Operating Income |
|
4.32
+210.78%
|
1.39
+128.05%
|
-4.96
+60.90%
|
-12.68
|
| Total Operating Income As Reported |
|
4.32
+210.78%
|
1.39
+128.05%
|
-4.96
+60.90%
|
-12.68
|
| EBITDA |
|
11.46
+69.83%
|
6.75
+363.41%
|
-2.56
+77.64%
|
-11.45
|
| Normalized EBITDA |
|
11.46
+69.83%
|
6.75
+396.27%
|
-2.28
+79.69%
|
-11.21
|
| Reconciled Depreciation |
|
1.54
-13.16%
|
1.77
+32.46%
|
1.34
-12.84%
|
1.53
|
| EBIT |
|
9.92
+99.38%
|
4.97
+227.63%
|
-3.90
+69.99%
|
-12.99
|
| Total Unusual Items |
|
—
|
0.95
+433.45%
|
-0.28
-16.39%
|
-0.24
|
| Total Unusual Items Excluding Goodwill |
|
—
|
0.95
+433.45%
|
-0.28
-16.39%
|
-0.24
|
| Net Income |
|
7.63
+161.31%
|
2.92
+169.60%
|
-4.20
+68.56%
|
-13.35
|
| Pretax Income |
|
7.71
+122.90%
|
3.46
+187.66%
|
-3.95
+69.73%
|
-13.03
|
| Net Non Operating Interest Income Expense |
|
3.39
+63.78%
|
2.07
+59.44%
|
1.30
+1312.15%
|
-0.11
|
| Interest Expense Non Operating |
|
2.21
+45.71%
|
1.52
+3058.33%
|
0.05
+4.35%
|
0.05
|
| Net Interest Income |
|
3.39
+63.78%
|
2.07
+59.44%
|
1.30
+1312.15%
|
-0.11
|
| Interest Expense |
|
2.21
+45.71%
|
1.52
+3058.33%
|
0.05
+4.35%
|
0.05
|
| Interest Income Non Operating |
|
5.60
+56.14%
|
3.58
+65.09%
|
2.17
+95.76%
|
1.11
|
| Interest Income |
|
5.60
+56.14%
|
3.58
+65.09%
|
2.17
+95.76%
|
1.11
|
| Other Income Expense |
|
—
|
0.95
+433.45%
|
-0.28
-16.39%
|
-0.24
|
| Gain On Sale Of Security |
|
—
|
0.95
+433.45%
|
-0.28
-16.39%
|
-0.24
|
| Tax Provision |
|
0.08
-85.69%
|
0.54
+114.34%
|
0.25
-20.32%
|
0.32
|
| Tax Rate For Calcs |
|
0.00
-93.58%
|
0.00
-32.38%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
+100.00%
|
-0.07
-16.39%
|
-0.06
|
| Net Income Including Noncontrolling Interests |
|
7.63
+161.31%
|
2.92
+169.60%
|
-4.20
+68.56%
|
-13.35
|
| Net Income From Continuing Operation Net Minority Interest |
|
7.63
+161.31%
|
2.92
+169.60%
|
-4.20
+68.56%
|
-13.35
|
| Net Income From Continuing And Discontinued Operation |
|
7.63
+161.31%
|
2.92
+169.60%
|
-4.20
+68.56%
|
-13.35
|
| Net Income Continuous Operations |
|
7.63
+161.31%
|
2.92
+169.60%
|
-4.20
+68.56%
|
-13.35
|
| Normalized Income |
|
7.63
+161.31%
|
2.92
+173.42%
|
-3.98
+69.77%
|
-13.16
|
| Net Income Common Stockholders |
|
7.63
+161.31%
|
2.92
+169.60%
|
-4.20
+68.56%
|
-13.35
|
| Diluted EPS |
|
—
|
0.09
+169.23%
|
-0.13
+67.50%
|
-0.40
|
| Basic EPS |
|
—
|
0.09
+169.23%
|
-0.13
+67.50%
|
-0.40
|
| Basic Average Shares |
|
—
|
32.46
+0.53%
|
32.28
-3.26%
|
33.37
|
| Diluted Average Shares |
|
—
|
32.46
+0.53%
|
32.28
-3.26%
|
33.37
|
| Diluted NI Availto Com Stockholders |
|
7.63
+296.52%
|
1.93
+145.87%
|
-4.20
+68.56%
|
-13.35
|
| Depreciation Amortization Depletion Income Statement |
|
—
|
0.40
+43.53%
|
0.28
-38.90%
|
0.46
|
| Depreciation And Amortization In Income Statement |
|
—
|
0.40
+43.53%
|
0.28
-38.90%
|
0.46
|
| Depreciation Income Statement |
|
—
|
0.40
+43.53%
|
0.28
-38.90%
|
0.46
|
| Provision For Doubtful Accounts |
|
—
|
0.57
+493.10%
|
-0.14
-151.60%
|
0.28
|
| Rent Expense Supplemental |
|
—
|
—
|
—
|
2.20
|
| Total Other Finance Cost |
|
—
|
1.23
+48.79%
|
0.83
-29.40%
|
1.17
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
112.92
+19.72%
|
94.32
+49.77%
|
62.97
-2.33%
|
64.48
|
| Current Assets |
|
84.89
+6.55%
|
79.67
+43.64%
|
55.47
-4.52%
|
58.09
|
| Cash Cash Equivalents And Short Term Investments |
|
69.13
-0.31%
|
69.34
+50.80%
|
45.98
-3.35%
|
47.58
|
| Cash And Cash Equivalents |
|
67.70
-2.37%
|
69.34
+559.17%
|
10.52
-77.89%
|
47.58
|
| Cash Equivalents |
|
—
|
55.28
|
0.00
-100.00%
|
40.27
|
| Cash Financial |
|
—
|
14.07
+33.73%
|
10.52
+43.97%
|
7.31
|
| Other Short Term Investments |
|
1.43
|
0.00
-100.00%
|
35.47
|
0.00
|
| Receivables |
|
4.11
-10.55%
|
4.60
+21.59%
|
3.78
-21.97%
|
4.84
|
| Accounts Receivable |
|
4.11
-10.55%
|
4.60
+21.59%
|
3.78
-21.97%
|
4.84
|
| Gross Accounts Receivable |
|
—
|
5.76
+22.93%
|
4.68
-21.21%
|
5.95
|
| Allowance For Doubtful Accounts Receivable |
|
—
|
-1.16
-28.54%
|
-0.90
+17.89%
|
-1.10
|
| Other Receivables |
|
—
|
—
|
—
|
0.61
|
| Inventory |
|
7.13
+61.18%
|
4.43
+19.07%
|
3.72
-3.13%
|
3.84
|
| Raw Materials |
|
—
|
2.79
+56.06%
|
1.79
-30.18%
|
2.56
|
| Work In Process |
|
—
|
0.21
-82.82%
|
1.21
-26.65%
|
1.65
|
| Finished Goods |
|
—
|
2.57
+40.37%
|
1.83
+49.39%
|
1.23
|
| Prepaid Assets |
|
—
|
—
|
—
|
—
|
| Restricted Cash |
|
0.25
-7.38%
|
0.27
+0.00%
|
0.27
+0.00%
|
0.27
|
| Other Current Assets |
|
4.26
+838.55%
|
0.45
-73.48%
|
1.71
+10.03%
|
1.56
|
| Total Non Current Assets |
|
28.03
+91.37%
|
14.65
+95.10%
|
7.51
+17.52%
|
6.39
|
| Net PPE |
|
12.17
+1.84%
|
11.95
+106.36%
|
5.79
+8.31%
|
5.35
|
| Gross PPE |
|
12.17
-32.71%
|
18.08
+49.63%
|
12.09
+11.45%
|
10.84
|
| Accumulated Depreciation |
|
—
|
-6.13
+2.54%
|
-6.29
-14.52%
|
-5.50
|
| Properties |
|
—
|
0.00
|
0.00
|
0.00
|
| Buildings And Improvements |
|
—
|
5.29
+1686.82%
|
0.30
|
—
|
| Machinery Furniture Equipment |
|
—
|
2.51
+30.83%
|
1.92
+27.91%
|
1.50
|
| Other Properties |
|
12.17
+23.06%
|
9.89
+1.24%
|
9.77
+5.46%
|
9.26
|
| Leases |
|
—
|
0.39
+286.27%
|
0.10
+25.93%
|
0.08
|
| Investments And Advances |
|
14.34
|
—
|
—
|
—
|
| Non Current Deferred Assets |
|
—
|
1.06
+28.38%
|
0.83
+200.00%
|
0.28
|
| Non Current Deferred Taxes Assets |
|
—
|
1.06
+28.38%
|
0.83
+200.00%
|
0.28
|
| Non Current Prepaid Assets |
|
—
|
1.64
+83.91%
|
0.89
+16.06%
|
0.77
|
| Other Non Current Assets |
|
1.52
|
—
|
—
|
1.04
|
| Total Liabilities Net Minority Interest |
|
39.70
+24.04%
|
32.00
+49.61%
|
21.39
+12.11%
|
19.08
|
| Current Liabilities |
|
22.16
+44.42%
|
15.35
+57.22%
|
9.76
+19.90%
|
8.14
|
| Payables And Accrued Expenses |
|
8.86
+45.91%
|
6.07
+53.62%
|
3.95
+12.75%
|
3.50
|
| Payables |
|
8.86
+153.45%
|
3.50
+137.43%
|
1.47
+23.08%
|
1.20
|
| Accounts Payable |
|
2.43
-15.34%
|
2.87
+278.36%
|
0.76
-32.08%
|
1.12
|
| Other Payable |
|
6.43
+1691.09%
|
0.36
+134.64%
|
0.15
|
—
|
| Current Accrued Expenses |
|
—
|
2.58
+3.87%
|
2.48
+7.41%
|
2.31
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
—
|
2.72
+31.91%
|
2.06
+10.55%
|
1.87
|
| Total Tax Payable |
|
—
|
0.27
-46.83%
|
0.50
|
0.00
|
| Income Tax Payable |
|
—
|
0.27
-46.83%
|
0.50
|
—
|
| Current Debt And Capital Lease Obligation |
|
1.07
+30.46%
|
0.82
+255.17%
|
0.23
-0.85%
|
0.23
|
| Current Capital Lease Obligation |
|
1.07
+30.46%
|
0.82
+255.17%
|
0.23
-0.85%
|
0.23
|
| Current Deferred Liabilities |
|
12.23
+113.55%
|
5.73
+63.07%
|
3.51
+137.78%
|
1.48
|
| Current Deferred Revenue |
|
12.23
+113.55%
|
5.73
+63.07%
|
3.51
+137.78%
|
1.48
|
| Other Current Liabilities |
|
—
|
—
|
1.01
-4.64%
|
1.06
|
| Total Non Current Liabilities Net Minority Interest |
|
17.53
+5.26%
|
16.66
+43.22%
|
11.63
+6.32%
|
10.94
|
| Long Term Debt And Capital Lease Obligation |
|
5.74
+19.63%
|
4.80
+1908.37%
|
0.24
-5.91%
|
0.25
|
| Long Term Capital Lease Obligation |
|
5.74
+19.63%
|
4.80
+1908.37%
|
0.24
-5.91%
|
0.25
|
| Non Current Deferred Liabilities |
|
11.79
+25.06%
|
9.43
-17.23%
|
11.39
+143.97%
|
4.67
|
| Non Current Deferred Revenue |
|
11.79
+25.06%
|
9.43
-17.23%
|
11.39
+143.97%
|
4.67
|
| Other Non Current Liabilities |
|
—
|
—
|
6.08
+1.01%
|
6.02
|
| Stockholders Equity |
|
73.22
+17.51%
|
62.31
+49.86%
|
41.58
-8.41%
|
45.40
|
| Common Stock Equity |
|
73.22
+17.51%
|
62.31
+49.86%
|
41.58
-8.41%
|
45.40
|
| Capital Stock |
|
0.43
+4.12%
|
0.41
+12.53%
|
0.37
+0.82%
|
0.36
|
| Common Stock |
|
0.43
+4.12%
|
0.41
+12.53%
|
0.37
+0.82%
|
0.36
|
| Share Issued |
|
39.16
+4.08%
|
37.63
+13.19%
|
33.24
+0.57%
|
33.05
|
| Ordinary Shares Number |
|
39.16
+4.08%
|
37.63
+13.19%
|
33.24
+0.57%
|
33.05
|
| Additional Paid In Capital |
|
162.22
+2.93%
|
157.60
+12.29%
|
140.34
+1.59%
|
138.15
|
| Retained Earnings |
|
-90.75
+7.76%
|
-98.38
+2.88%
|
-101.30
-4.32%
|
-97.11
|
| Gains Losses Not Affecting Retained Earnings |
|
-2.19
+0.00%
|
-2.19
+0.00%
|
-2.19
+0.00%
|
-2.19
|
| Other Equity Adjustments |
|
—
|
—
|
—
|
—
|
| Total Equity Gross Minority Interest |
|
73.22
+17.51%
|
62.31
+49.86%
|
41.58
-8.41%
|
45.40
|
| Total Capitalization |
|
73.22
+17.51%
|
62.31
+49.86%
|
41.58
-8.41%
|
45.40
|
| Working Capital |
|
62.73
-2.48%
|
64.32
+40.74%
|
45.70
-8.50%
|
49.95
|
| Invested Capital |
|
73.22
+17.51%
|
62.31
+49.86%
|
41.58
-8.41%
|
45.40
|
| Total Debt |
|
6.82
+21.21%
|
5.62
+1094.06%
|
0.47
-3.48%
|
0.49
|
| Capital Lease Obligations |
|
6.82
+21.21%
|
5.62
+1094.06%
|
0.47
-3.48%
|
0.49
|
| Net Tangible Assets |
|
73.22
+17.51%
|
62.31
+49.86%
|
41.58
-8.41%
|
45.40
|
| Tangible Book Value |
|
73.22
+17.51%
|
62.31
+49.86%
|
41.58
-8.41%
|
45.40
|
| Available For Sale Securities |
|
14.34
|
—
|
—
|
—
|
| Derivative Product Liabilities |
|
0.00
-100.00%
|
2.43
|
0.00
|
—
|
| Dueto Related Parties Current |
|
—
|
0.11
+91.23%
|
0.06
-28.75%
|
0.08
|
| Foreign Currency Translation Adjustments |
|
-2.19
+0.00%
|
-2.19
+0.00%
|
-2.19
+0.00%
|
-2.19
|
| Inventories Adjustments Allowances |
|
—
|
-1.15
-2.86%
|
-1.12
+30.39%
|
-1.61
|
| Investmentin Financial Assets |
|
14.34
|
—
|
—
|
—
|
| Other Equity Interest |
|
3.51
-28.04%
|
4.87
+11.74%
|
4.36
-29.45%
|
6.18
|
| Other Inventories |
|
—
|
—
|
—
|
3.84
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
18.02
+74.99%
|
10.30
+702.02%
|
1.28
+113.16%
|
-9.76
|
| Cash Flow From Continuing Operating Activities |
|
18.02
+74.99%
|
10.30
+702.02%
|
1.28
+113.16%
|
-9.76
|
| Net Income From Continuing Operations |
|
7.63
+161.31%
|
2.92
+169.60%
|
-4.20
+68.56%
|
-13.35
|
| Depreciation Amortization Depletion |
|
1.54
-13.16%
|
1.77
+32.46%
|
1.34
-12.84%
|
1.53
|
| Depreciation |
|
1.54
-13.16%
|
1.77
+32.46%
|
1.34
-12.84%
|
1.53
|
| Depreciation And Amortization |
|
1.54
-13.16%
|
1.77
+32.46%
|
1.34
-12.84%
|
1.53
|
| Other Non Cash Items |
|
-3.39
-63.78%
|
-2.07
-104.15%
|
-1.01
-388.60%
|
0.35
|
| Stock Based Compensation |
|
1.20
-17.00%
|
1.44
+278.22%
|
0.38
-74.15%
|
1.47
|
| Asset Impairment Charge |
|
0.04
-97.30%
|
1.52
+4.98%
|
1.45
+77.33%
|
0.82
|
| Deferred Tax |
|
0.08
-85.69%
|
0.54
+114.34%
|
0.25
-20.32%
|
0.32
|
| Deferred Income Tax |
|
0.08
-85.69%
|
0.54
+114.34%
|
0.25
-20.32%
|
0.32
|
| Change In Working Capital |
|
7.59
+217.80%
|
2.39
+45.99%
|
1.64
+212.45%
|
-1.45
|
| Change In Receivables |
|
0.61
+170.01%
|
-0.87
-179.61%
|
1.09
-25.21%
|
1.46
|
| Changes In Account Receivables |
|
0.61
+170.01%
|
-0.87
-179.61%
|
1.09
-25.21%
|
1.46
|
| Change In Inventory |
|
-1.99
-116.20%
|
-0.92
-81.82%
|
-0.51
+85.92%
|
-3.60
|
| Change In Payables And Accrued Expense |
|
0.24
-89.28%
|
2.25
+948.30%
|
-0.27
-188.93%
|
0.30
|
| Change In Payable |
|
0.24
-89.28%
|
2.25
+948.30%
|
-0.27
-188.93%
|
0.30
|
| Change In Account Payable |
|
-0.48
-122.51%
|
2.12
+748.01%
|
-0.33
|
0.00
|
| Change In Other Working Capital |
|
9.25
+3240.79%
|
0.28
-83.00%
|
1.63
+106.20%
|
0.79
|
| Change In Other Current Assets |
|
-0.53
-131.96%
|
1.65
+628.53%
|
-0.31
+22.58%
|
-0.40
|
| Investing Cash Flow |
|
-17.49
-157.71%
|
30.31
+181.03%
|
-37.41
-188.71%
|
42.17
|
| Cash Flow From Continuing Investing Activities |
|
-17.49
-157.71%
|
30.31
+181.03%
|
-37.41
-188.71%
|
42.17
|
| Net PPE Purchase And Sale |
|
-1.75
+53.95%
|
-3.79
-58.94%
|
-2.39
-223.30%
|
1.94
|
| Purchase Of PPE |
|
-1.75
+53.95%
|
-3.79
|
—
|
—
|
| Capital Expenditure |
|
-1.75
+53.95%
|
-3.79
-58.94%
|
-2.39
|
—
|
| Net Investment Purchase And Sale |
|
-15.77
-146.33%
|
34.03
+197.16%
|
-35.02
-187.05%
|
40.23
|
| Purchase Of Investment |
|
-15.77
-1523.69%
|
-0.97
+97.23%
|
-35.02
-166671.43%
|
-0.02
|
| Sale Of Investment |
|
0.00
-100.00%
|
35.00
|
0.00
-100.00%
|
40.25
|
| Net Other Investing Changes |
|
0.02
-73.68%
|
0.08
|
—
|
—
|
| Financing Cash Flow |
|
-2.21
-112.12%
|
18.26
+1880.02%
|
-1.03
+33.68%
|
-1.55
|
| Cash Flow From Continuing Financing Activities |
|
-2.21
-112.12%
|
18.26
+1880.02%
|
-1.03
+33.68%
|
-1.55
|
| Net Issuance Payments Of Debt |
|
-0.83
-96.23%
|
-0.42
-56.46%
|
-0.27
+49.16%
|
-0.53
|
| Repayment Of Debt |
|
-0.83
-96.23%
|
-0.42
-56.46%
|
-0.27
+49.16%
|
-0.53
|
| Long Term Debt Payments |
|
-0.83
-96.23%
|
-0.42
-56.46%
|
-0.27
+49.16%
|
-0.53
|
| Net Long Term Debt Issuance |
|
-0.83
-96.23%
|
-0.42
-56.46%
|
-0.27
+49.16%
|
-0.53
|
| Net Common Stock Issuance |
|
0.00
-100.00%
|
16.35
|
0.00
+100.00%
|
-0.05
|
| Common Stock Payments |
|
—
|
0.00
|
0.00
+100.00%
|
-0.05
|
| Repurchase Of Capital Stock |
|
—
|
0.00
|
0.00
+100.00%
|
-0.05
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
3.44
|
0.00
|
0.00
|
| Net Other Financing Charges |
|
-1.38
-24.73%
|
-1.11
-46.75%
|
-0.76
+21.52%
|
-0.96
|
| Changes In Cash |
|
-1.69
-102.87%
|
58.87
+258.47%
|
-37.15
-220.38%
|
30.86
|
| Effect Of Exchange Rate Changes |
|
0.04
+189.36%
|
-0.05
-152.22%
|
0.09
+144.55%
|
-0.20
|
| Beginning Cash Position |
|
69.34
+559.17%
|
10.52
-77.89%
|
47.58
+181.19%
|
16.92
|
| End Cash Position |
|
67.70
-2.37%
|
69.34
+559.17%
|
10.52
-77.89%
|
47.58
|
| Free Cash Flow |
|
16.27
+150.20%
|
6.50
+689.66%
|
-1.10
+88.70%
|
-9.76
|
| Common Stock Issuance |
|
0.00
-100.00%
|
16.35
|
0.00
|
0.00
|
| Interest Paid CFO |
|
-0.11
+9.68%
|
-0.12
+50.99%
|
-0.25
-450.00%
|
-0.05
|
| Interest Received CFO |
|
4.08
+39.70%
|
2.92
+71.18%
|
1.71
+63.82%
|
1.04
|
| Issuance Of Capital Stock |
|
0.00
-100.00%
|
16.35
|
0.00
|
0.00
|
| Taxes Refund Paid |
|
-0.63
+37.17%
|
-1.01
-9072.73%
|
-0.01
+97.52%
|
-0.44
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|